Page last updated: 2024-08-23

4-methoxyamphetamine and AIDS-Related Opportunistic Infections

4-methoxyamphetamine has been researched along with AIDS-Related Opportunistic Infections in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hoover, DR; Moore, RD; Xiong, C; Yan, Y	1
Bangsberg, DR; Charlebois, E; Clark, R; Guzman, D; Kagay, CR; Liechty, CA; Moss, AR; Porco, TC	1

Other Studies

2 other study(ies) available for 4-methoxyamphetamine and AIDS-Related Opportunistic Infections

Article	Year
Multivariate estimation of cumulative incidence, prevalence, and morbidity time of a disease when death is likely. Journal of clinical epidemiology, 2003, Volume: 56, Issue:6 Topics: AIDS-Related Opportunistic Infections; Baltimore; Confounding Factors, Epidemiologic; Cytomegalovirus Infections; Death; Health Services Needs and Demand; Health Services Research; Humans; Incidence; Morbidity; Prevalence; Prognosis; Proportional Hazards Models; Risk; Survival Analysis	2003
Modeling the impact of modified directly observed antiretroviral therapy on HIV suppression and resistance, disease progression, and death. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jun-01, Volume: 38 Suppl 5 Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Death; Directly Observed Therapy; Disease Progression; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Models, Statistical; Patient Compliance	2004

Article

Year

Multivariate estimation of cumulative incidence, prevalence, and morbidity time of a disease when death is likely.

Journal of clinical epidemiology, 2003, Volume: 56, Issue:6

Topics: AIDS-Related Opportunistic Infections; Baltimore; Confounding Factors, Epidemiologic; Cytomegalovirus Infections; Death; Health Services Needs and Demand; Health Services Research; Humans; Incidence; Morbidity; Prevalence; Prognosis; Proportional Hazards Models; Risk; Survival Analysis

2003

Modeling the impact of modified directly observed antiretroviral therapy on HIV suppression and resistance, disease progression, and death.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jun-01, Volume: 38 Suppl 5

Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Death; Directly Observed Therapy; Disease Progression; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Models, Statistical; Patient Compliance

2004